Literature DB >> 2106136

Relationship between protein synthesis and concentrations of charged and uncharged tRNATrp in Escherichia coli.

M V Rojiani1, H Jakubowski, E Goldman.   

Abstract

We have continuously monitored Trp-tRNA(Trp) concentrations in vivo and, in the same cultures, measured rates of protein synthesis in isogenic stringent and relaxed strains. We have also manipulated cellular charged and uncharged [tRNA(Trp)] by two means: (i) the strain used contains a Trp-tRNA synthetase mutation that increases the Km for Trp; thus, varying exogenous Trp varies cellular Trp-tRNA(Trp); and (ii) we have introduced into the mutant strain a plasmid containing the tRNA(Trp) gene behind an inducible promoter; thus, total [tRNA(Trp)] also can be varied depending on length of induction. The use of these conditions, combined with a previously characterized assay system, has allowed us to demonstrate that (i) the rate of incorporation of Trp into protein is proportional to the fraction of tRNA(Trp) that is charged; for any given total [tRNA(Trp)], this rate is also proportional to the [Trp-tRNA(Trp)]; (ii) uncharged tRNA(Trp) inhibits incorporation of Trp into protein; and (iii) rates of incorporation into protein of at least two other amino acids, Lys and Cys, are also sensitive to [Trp-tRNA(Trp)] and are inhibited by uncharged tRNA(Trp). Our results are consistent with models of translational control that postulate modulating polypeptide chain elongation efficiency by varying concentrations of specific tRNAs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106136      PMCID: PMC53505          DOI: 10.1073/pnas.87.4.1511

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Incomplete aminoacylation of tRNALeu catalyzed in vitro by leucyl-tRNA synthetase from Escherichia coli B.

Authors:  H Jakubowski
Journal:  Biochim Biophys Acta       Date:  1978-04-27

Review 2.  Stringent control in E. coli.

Authors:  J A Gallant
Journal:  Annu Rev Genet       Date:  1979       Impact factor: 16.830

3.  Codon-anticodon interaction at the ribosomal peptidyl-site.

Authors:  R Lührmann; H Eckhardt; G Stöffler
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

4.  Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes.

Authors:  W A Haseltine; R Block
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

5.  Tryptophanyl-tRNA and tryptophanyl-tRNA synthetase are not required for in vitro repression of the tryptophan operon.

Authors:  C L Squires; J K Rose; C Yanofsky; H L Yang; G Zubay
Journal:  Nat New Biol       Date:  1973-10-03

6.  Codon-specific binding of deacylated transfer ribonucleic acid to ribosomes.

Authors:  J G Levin
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

7.  Mutants of Escherichia coli with an altered tryptophanyl-transfer ribonucleic acid synthetase.

Authors:  W F Doolittle; C Yanofsky
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

8.  The effect of tRNA concentration on the rate of protein synthesis.

Authors:  W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

9.  Effect of variation of charged and uncharged tRNA(Trp) levels on ppGpp synthesis in Escherichia coli.

Authors:  M V Rojiani; H Jakubowski; E Goldman
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

10.  Three tRNA binding sites on Escherichia coli ribosomes.

Authors:  H J Rheinberger; H Sternbach; K H Nierhaus
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  11 in total

1.  Function of a relaxed-like state following temperature downshifts in Escherichia coli.

Authors:  P G Jones; M Cashel; G Glaser; F C Neidhardt
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

2.  Evidence for aminoacylation-induced conformational changes in human mitochondrial tRNAs.

Authors:  J A Enríquez; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 3.  Engineering genes for predictable protein expression.

Authors:  Claes Gustafsson; Jeremy Minshull; Sridhar Govindarajan; Jon Ness; Alan Villalobos; Mark Welch
Journal:  Protein Expr Purif       Date:  2012-03-08       Impact factor: 1.650

Review 4.  Synonymous Codons: Choose Wisely for Expression.

Authors:  Christina E Brule; Elizabeth J Grayhack
Journal:  Trends Genet       Date:  2017-03-12       Impact factor: 11.639

5.  Simple and efficient method for heterologous expression of clostridial proteins.

Authors:  A G Zdanovsky; M V Zdanovskaia
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

6.  Characterization of the stringent and relaxed responses of Streptococcus equisimilis.

Authors:  U Mechold; H Malke
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

7.  tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes.

Authors:  Wenyi Gu; Mengrong Li; Wei Ming Zhao; Ning Xia Fang; Shurui Bu; Ian H Frazer; Kong-Nan Zhao
Journal:  Nucleic Acids Res       Date:  2004-08-19       Impact factor: 16.971

8.  Increased ribosomal accuracy increases a programmed translational frameshift in Escherichia coli.

Authors:  J Sipley; E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli.

Authors:  B J Del Tito; J M Ward; J Hodgson; C J Gershater; H Edwards; L A Wysocki; F A Watson; G Sathe; J F Kane
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

10.  Design parameters to control synthetic gene expression in Escherichia coli.

Authors:  Mark Welch; Sridhar Govindarajan; Jon E Ness; Alan Villalobos; Austin Gurney; Jeremy Minshull; Claes Gustafsson
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.